Connect with us

Business

Britain’s Serious Fraud Office opens investigation into Bombardier

Published

 on

Bombardier says it is co-operating with an investigation by Britain’s Serious Fraud Office.

ARND WIEGMANN/Reuters

Britain’s Serious Fraud Office has opened an investigation into Bombardier Inc. over suspected bribery and corruption, adding to the adversity facing the plane maker as it prepares to scale back its business further to adapt to still-shaky market conditions.

The probe is related to contracts and orders from Garuda Indonesia, the flag airline of the Southeast Asian country, the fraud office said in a statement on its website Thursday. It said it would provide no further comment because the investigation is continuing.

Bombardier confirmed the investigation and said it has launched its own review of the matter, conducted by external counsel. No charges have been laid against Bombardier or its employees in connection with the affair, the company said.

Story continues below advertisement

“This is unfortunate,” Bombardier chief executive Éric Martel told reporters on a conference call after the company’s third-quarter earnings report Thursday. He said while probes by authorities so far have centred on sales made to Garuda by Airbus SE and British-based engine maker Rolls-Royce Holdings PLC, the fraud office informed the company several weeks ago that it wanted to investigate Bombardier because it also sold aircraft to the Indonesian carrier.

“They reached out to us. We were not aware of any issues internally,” Mr. Martel said. “We’re being very open. We’re co-operating with the investigation. We’ll provide the information they need and we’ll see how this situation progresses.”

The inquiry presents a new wrinkle in Mr. Martel’s effort to reshape Bombardier into a single-business maker of private jets in the months ahead. The company has sold off all its commercial aircraft manufacturing capability to Airbus, Mitsubishi Heavy Industries Ltd. and Longview Aviation Capital Corp., and plans to unload its train business to Alstom SA in a crucial transaction scheduled to close next year.

Bombardier shares ended the day up 1.7 per cent in trading on the Toronto Stock Exchange, closing at 30 cents.

The Indonesia probe is one of a number of legal files outstanding for Bombardier.

The company also faces a continuing police investigation in Sweden and an audit by the World Bank related to a 2013 contract for the supply of rail signalling equipment to Azerbaijan Railways. A Swedish Court acquitted a Bombardier employee three years ago of bribery in relation to that contract, but the case is likely to go to appeal.

The U.S. Department of Justice contacted the company earlier this year requesting documents and information about that contract, Bombardier disclosed in a regulatory filing Thursday. The company said that based on the information it has, there is no evidence to suggest that any criminal activity involving Bombardier took place.

Story continues below advertisement

In the filing, Bombardier also provided some additional context about the Serious Fraud Office probe. It said that in May, 2020, the Indonesian Corruption Court convicted the former chief executive of Garuda Indonesia and his associate of corruption and money laundering in connection with five procurement processes involving different manufacturers, including the 2011-12 acquisition and lease of Bombardier CRJ1000 aircraft by Garuda Indonesia.

Bombardier launched an internal review of the Garuda transactions shortly after that conviction, the company said. It said it understands that the Serious Fraud Office’s investigation involves the same transactions.

Garuda currently operates 18 Bombardier CRJ1000 regional jets among a fleet of 142 planes, according to its website. Bombardier announced a purchase agreement with the airline in February, 2012, during a news briefing at the Singapore air show.

At the time, Garuda agreed to buy six CRJ1000 planes and took an option on another 12 aircraft. The total value of the deal was US$1.32-billion, according to Bombardier’s news release.

The development comes as Mr. Martel readies a new strategic plan for Bombardier in the weeks ahead based on the results of an analysis of its operations and projected finances as a standalone business jet maker. The company needs to make major adjustments to improve profitability as a much smaller company, he said.

“Our cost structure today is much too large for the size of the business that we’ll have,” Mr. Martel told reporters, adding Bombardier factories have become too costly. “This will definitely mean layoffs,” he said. “What I can’t say today is where or when.”

Bombardier on Thursday reported a net profit of US$192-million in its third quarter, reversing a net loss of US$91-million in the same quarter last year. Revenue totalled about US$3.53-billion, down 5 per cent from a year ago.

Source link

Continue Reading

Business

Voluntary recall issued for Frank’s RedHot Buffalo Ranch Seasoning – Global News

Published

 on


A voluntary recall has been issued for Frank’s RedHot Buffalo Ranch Seasoning over a possible Salmonella contamination.

McCormick & Company, Inc. says the recall covers 153g bottles with a best before date of September 6, 2022.

Read more:
18 more hand sanitizers added to Health Canada’s growing recall list

The bottles were shipped to British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and Quebec.

No illnesses have been reported, and McCormick says the potential risk was brought to their attention by the FDA during routine testing.

Read more:
Health Canada recalls children’s jewellery over lead, cadmium levels

Salmonella poisoning can result in a wide range of symptoms, from short-term fever, headache and nausea to more serious issues including severe arthritis and, in rare cases, even death.

© 2021 The Canadian Press

Adblock test (Why?)



Source link

Continue Reading

Business

Pfizer sells $7.8 billion in Covid shots in the second quarter, raises 2021 guidance on vaccine sales – CNBC

Published

 on


In this article

A person walks past the Pfizer building in New York City, March 2, 2021.
Carlo Allegri | Reuters

Pfizer said Wednesday it sold $7.8 billion in Covid-19 shots in the second quarter and raised its 2021 sales forecast for the vaccine to $33.5 billion from $26 billion, as the delta variant spreads and scientists debate whether people will need booster shots.

The company’s second-quarter financial results also beat Wall Street expectations on earnings and revenue. Here’s how Pfizer did compared with what Wall Street expected, according to average estimates compiled by Refinitiv:

  • Adjusted earnings per share: $1.07 per share vs. 97 cents per share expected
  • Revenue: $18.98 billion vs. $18.74 billion forecast

Pfizer expects an adjusted pretax profit in the high 20% range of revenue for the vaccine.

The company now expects full-year earnings in the range of $3.95 to $4.05 per share. That’s up from its prior range of $3.55 to $3.65 per share. It expects revenue in the range of $78 billion to $80 billion, up from its previous estimate of $70.5 billion to $72.5 billion.

Shares of Pfizer dipped 0.4% in premarket trading.

“The second quarter was remarkable in a number of ways,” Pfizer CEO Albert Bourla said in a statement. “Most visibly, the speed and efficiency of our efforts with BioNTech to help vaccinate the world against COVID-19 have been unprecedented, with now more than a billion doses of BNT162b2 having been delivered globally.”

Pfizer’s other business units also saw strong sales growth. Revenue from its oncology unit rose by 19% year over year to $3.1 billion. The company’s hospital unit generated $2.2 billion in revenue, up 21% from the prior year. Its internal medicine unit grew by 5% from a year ago to $2.4 billion.

Pfizer said earlier this month it was seeing signs of waning immunity induced by its Covid vaccine with German drugmaker BioNTech, and planned to ask the Food and Drug Administration to authorize a booster dose. It also said it is developing a booster shot to target the delta variant.

In slides posted Wednesday alongside its earnings report, Pfizer said it could potentially file for an emergency use authorization for a booster dose with the FDA as early as August. It expects to begin clinical studies testing its delta variant vaccine in the same month.

It expects full approval for its two-dose vaccine by January 2022.

Adblock test (Why?)



Source link

Continue Reading

Business

Pearson airport won’t sort arriving passengers based on COVID-19 vaccination status – CityNews Toronto

Published

 on


Canada’s largest airport is no longer splitting arriving international passengers into different customs lines based on their vaccination status.

Toronto’s Pearson International Airport announced last week it may be sorting travellers arriving from the U.S. or other international locations into vaccinated and partially or non-vaccinated queues.

But a spokesperson for the Greater Toronto Airports Authority says the practice has been discontinued as of Monday.

Beverly MacDonald says in a statement that the airport has determined separating vaccinated and partially or non-vaccinated travellers into different customs lines “results in minimal operational efficiencies.”

She says entry requirements related to vaccination status will now be enforced once a passenger reaches a customs officer.

Fully vaccinated Canadian citizens and permanent residents are now able to forgo a 14-day quarantine when arriving in Canada from abroad.

Adblock test (Why?)



Source link

Continue Reading

Trending